The ROA (Return on Assets) of Hansa Biopharma AB (HNSA.ST) is -100.82%.
ROA (Return on Assets) calculates how much net income a company earns relative to its total assets. It reveals how efficiently a business is managing its resources.
| Date | Value |
|---|---|
| 2024-12-31 | -100.82% |
| 2023-12-31 | -81.70% |
| 2022-12-31 | -36.22% |
| 2021-12-31 | -54.13% |
| 2020-12-31 | -29.34% |
| 2019-12-31 | -54.20% |
| 2018-12-31 | -26.25% |
| 2017-12-31 | -25.96% |
| 2016-12-31 | -35.77% |
| 2015-12-31 | -29.57% |